Levetiracetam Ucb (Levetiracetam)

Levetiracetam works by binding to the synaptic vesicle protein SV2A, which modulates neurotransmitter release. This interaction stabilizes neuronal activity and diminishes abnormal electrical discharges that trigger seizures, providing broad-spectrum seizure control without directly influencing ion channels or GABA receptors.

The appropriate dose of levetiracetam is individualized by the prescribing clinician based on the patient’s age, renal function, seizure type, and treatment response. Dosage adjustments are made to achieve optimal seizure control while minimizing side effects, and patients should follow the specific instructions provided by their healthcare provider.

Levetiracetam is classified as pregnancy category unknown because limited data are available. It should only be used during pregnancy or lactation if the potential benefits outweigh the risks. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives and monitoring strategies with their physician.

To order Levetiracetam Ucb, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Levetiracetam offers a favorable safety profile and few drug‑enzyme interactions compared with many older antiepileptics such as carbamazepine or phenytoin. It is often chosen for its broad seizure coverage, rapid titration, and minimal impact on hepatic metabolism, though individual response and tolerability vary among patients.

Levetiracetam Ucb tablets should be stored at room temperature, below 25 °C, in the original packaging to protect from moisture and light. Keep the product out of reach of children and avoid storing in humid or excessively hot environments to maintain potency.

Levetiracetam is administered orally, usually as a tablet that can be swallowed whole with water. It may be taken with or without food, and dosing frequency is determined by the prescriber, often once or twice daily depending on the therapeutic regimen.

Serious risks include severe allergic reactions such as anaphylaxis, skin conditions like Stevens‑Johnson syndrome, blood disorders (e.g., neutropenia), and neuropsychiatric effects such as suicidal thoughts or major depression. Patients should seek immediate medical attention if they experience rash, swelling, mood changes, or any signs of an allergic reaction.

Levetiracetam is contraindicated in individuals with known hypersensitivity to the drug or any of its excipients. Caution is advised for patients with severe renal impairment, uncontrolled psychiatric disorders, or those taking interacting medications that may markedly reduce its effectiveness. A healthcare professional should evaluate suitability before initiating therapy.